ARTICLE | Company News
Cell Genesys anniversary payment
February 2, 2000 8:00 AM UTC
CEGE received $2 million from Aventis (AVE) in connection with the anniversary of the companies' 1997 agreement, under which AVE has a license to CEGE's gene activation technology for erythropoietin a...